4//SEC Filing
Nassif David W. 4
Accession 0001636050-21-000031
CIK 0001636050other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 9:25 PM ET
Size
7.1 KB
Accession
0001636050-21-000031
Insider Transaction Report
Form 4
Nassif David W.
Principal Financial Officer
Transactions
- Award
Common Stock
2021-03-22+15,060→ 34,004 total - Disposition to Issuer
Restricted Stock Units
2021-03-22−15,060→ 0 total→ Common Stock (15,060 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted.
Documents
Issuer
Sio Gene Therapies Inc.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001636975
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 9:25 PM ET
- Size
- 7.1 KB